Search

Search Constraints

You searched for: Author/Creator Farrell, Christopher

Search Results

2. RTHP-10. LESS IS MORE OR BIGGER IS BETTER? RADIATION TREATMENT VOLUME FOR GLIOBLASTOMA PATIENTS DOES NOT IMPACT SURVIVAL. (5th November 2018)

4. Predicting prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenoma. Issue 6 (3rd May 2020)

5. ACTR-49. INITIAL EXPERIENCE WITH SCALP PRESERVATION AND RADIATION PLUS CONCURRENT ALTERNATING ELECTRIC TUMOR-TREATING FIELDS (SPARE) FOR GLIOBLASTOMA PATIENTS. (11th November 2019)

6. RADT-13. SPARE TRIAL: SCALP-SPARING RADIATION WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (12th November 2021)

7. CTNI-19. CONCURRENT CHEMORADIATION AND TUMOR TREATING FIELDS (TTFields, 200 kHz) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MAY INCREASE THE RATE OF DISTANT RECURRENCE. (12th November 2021)

8. RADT-22. CONCURRENT TTFIELDS (200 KHZ) WITH CHEMORADIATION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MAY INCREASE THE RATE OF PSEUDOPROGRESSION: ANALYSIS OF A PILOT CLINICAL TRIAL. (12th November 2021)

10. An algorithm for sellar reconstruction following endoscopic transsphenoidal surgery for pituitary adenoma: A review of 582 cases. Issue 9 (9th February 2022)